Developer docs
API playgroundTry for free, no card

Search company profiles

Partners Investment

Full company profile

uuid0000uk3

Namestring
Partners Investment
Legal namestring
Partners Investment Co., Ltd. (파트너스인베스트먼트)
Websiteurl
partnersi.co.kr
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Partners Investment Co., Ltd. (파트너스인베스트먼트) is a Seoul-based venture capital and private equity firm that traces its origins to 2000, when it was established as Partners Venture Capital. The firm rebranded to its current name in 2014 and completed a physical spin-off from Partners Holdings in 2019 to operate as an independent fund management platform. It manages 21 fund vehicles spanning venture, growth, secondary, M&A, co-investment, and global healthcare strategies, with total assets under management of approximately 11,746억원 won and roughly 7,150억원 won of cumulative capital deployed across a portfolio of 80+ companies as of March 2026.

The firm invests in Korean growth-stage SMEs across three core verticals: ICT (software, semiconductors, electronics, telecommunications), Bio & Healthcare (biotechnology, medical devices, healthcare services), and Internet & Mobile (digital media, fintech, gaming, e-learning). Recent 2026 deployments include co-investments in BOS Semiconductors (AI mobility accelerator chips, ~87 billion won Series A) and SOLIVIS (sulfide solid electrolytes for all-solid-state batteries, ~$13.7M Series C), signaling expansion into deep-tech hardware. Beyond capital, the firm provides hands-on stewardship including board representation, operational consulting in finance/sales/strategy, and periodic portfolio monitoring, governed by its adoption of the Korean Stewardship Code since October 2019.

Revenue is generated through management fees and carried interest on fund operations. The limited partner base is heavily institutional: government agencies (46%), financial institutions (32%), pensions and mutual aid associations (10%), and industrial/strategic companies (12%). Leadership is led by CEO Kim Jae-wan (former 12-year Samsung Venture Investment executive) with a senior team spanning biotech, semiconductors, mobility, and consulting backgrounds. The firm has received multiple "Best Fund" and industry awards from Korea Venture Investment, the Financial Services Commission, and Korea Growth Finance.

Short descriptiontext

Partners Investment is a Seoul-based venture capital and private equity firm managing approximately 11,746억원 won (~$850M) across 21 funds, investing growth-stage capital into Korean SMEs across ICT, Bio & Healthcare, and Internet & Mobile sectors, with revenue from management fees and carried interest.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital, private equity funds, growth-stage investment, portfolio management, stewardship services
Industry3 codes
1Multi-Sector / Generalist Growth Equity
CodeFSANACAOPrimaryYes
2Technology & Software Growth Equity
CodeFSANACAAPrimaryNo
3Sector-Focused Venture Capital (Vertical Specialists)
CodeFSANAAADPrimaryNo
NAICS code3 codes
  • All Other Financial Investment Activities52399
  • Other Investment Pools and Funds5259
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital and Private Equity Fund Management
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Fund Management
TypeLicensing Royalties
Description

Partners Investment generates revenue through managing multiple venture capital and private equity funds. The firm raises capital from LPs including government agencies (46%), financial institutions (32%), pensions (10%), and industrial companies (12%), and earns management fees and carried interest from fund operations and portfolio company exits.

partnersi.co.kr
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Partners Investment is a Seoul-based venture capital and private equity firm that manages 21 fund vehicles deploying growth capital into Korean SMEs. It raises capital from institutional limited partners and invests across the ICT, Bio & Healthcare, and Internet & Mobile sectors, while providing hands-on stewardship and value-creation support to portfolio companies through board participation, operational consulting, and strategic guidance.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Partners Investment is a Korean venture capital and private equity firm that operates a diverse portfolio of investment funds targeting growth-stage SMEs. The firm manages multiple fund vehicles across different strategies including venture funds (Partners 2호 through 11호), secondary funds, growth support funds, M&A funds, healthcare-focused funds, and growth-together funds. Fund sizes range from 55억 원 to 2,400억 원 in committed capital. The firm focuses its investments on high-growth sectors including Software, Media/Entertainment, IT Services, Biotechnology, Medical Devices, Healthcare Services, Electronics/Semiconductors, Telecommunications, and Industrial/Energy. As a responsible partner to portfolio companies, Partners Investment provides stewardship services including financial management support, operational consulting, and strategic value enhancement. The firm has approximately 11,746억 원 in assets under management and 7,150억 원 in unrealized value as of March 2026.

Product and service7 records
1Partners Venture Capital Fund Series (Partners 2nd through 11th Investment Partnerships)
CategoryVenture Capital Fund
Description

Sequential venture capital fund vehicles deploying growth capital into Korean SMEs across ICT, Bio & Healthcare, and Internet & Mobile sectors.

2Partners M&A Investment Partnership
CategoryM&A Fund
Description

M&A-focused private equity fund targeting buyout and consolidation opportunities in Korean SMEs.

3Partners 7th Secondary Investment Partnership
CategorySecondary Fund
Description

Secondary investment fund providing liquidity to investors in existing private equity and venture capital portfolios.

4Partners Growth Support Investment Partnership (8th Fund)
CategoryGrowth Support Fund
Description

Growth capital fund providing expansion financing and operational support to high-growth Korean SMEs.

5Partners Global Healthcare Fund Series (Funds 1, 3, and 4)
CategoryHealthcare Private Equity Fund
Description

Healthcare-focused private equity funds investing in biotechnology, medical devices, and healthcare services companies globally.

6Investment Partnership Operation Service
CategoryInvestment Management Service
Description

Core fund management service covering investment sourcing, due diligence, portfolio construction, and post-investment support across multiple sectors including Software, IT Services, Biotechnology, Medical Devices, Electronics, Semiconductors, Telecommunications, and Industrial/Energy.

7Portfolio Company Stewardship Service
CategoryPortfolio Management and Stewardship Service
Description

Stewardship service for portfolio companies including periodic monitoring through ERP-based tracking, regular management consultations, board participation, voting rights exercise, and strategic value enhancement initiatives such as executive reinforcement and operational efficiency improvements.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Atinum is a major Korean VC/PE firm focused on growth-stage technology, biotech, and healthcare investments. It co-invested alongside Partners Investment in BOS Semiconductors' Series A, indicating directly overlapping deal pipelines in Korean deep-tech.

TypeDirect peer
Description

Premier Partners is a Korean VC/PE firm with comparable growth-stage and sector-specialized focus, and is a previous employer of Partners Investment's Managing Director Sim Su-min. Operates similar fund vintages targeting Korean SMEs.

TypeBroad incumbent
Description

KB Investment is the venture/PE arm of KB Financial Group, one of Korea's largest financial conglomerates. Co-invested alongside Partners Investment in BOS Semiconductors. Larger and more diversified, but directly competes for top Korean growth deals with greater capital backing.

TypeDirect peer
Description

LB Investment is a leading Korean growth-stage VC/PE firm with strong ICT and biotech sector coverage and a comparable LP base anchored by Korean institutional capital. Directly competes for Korean SME growth deals.

TypeDirect peer
Description

Smilegate Investment is a Korean VC/PE firm with strong deep-tech and gaming/internet focus. Co-invested with Partners Investment in BOS Semiconductors' Series A, indicating directly overlapping Korean deep-tech deal flow.

TypeDirect peer
Description

Mirae Asset Venture Investment is a top-tier Korean VC affiliate of Mirae Asset Group with multi-sector investment focus including ICT, biotech, and consumer. Directly comparable in fund scale, LP composition, and sector verticals.

TypeDirect peer
Description

Daesung Venture Capital is a Korean VC firm with sector coverage overlapping Partners Investment's ICT and bio verticals. It is a previous employer of Partners Investment team member Kim Jun-soo.

TypeDirect peer
Description

Korea Investment Partners is one of Korea's largest and most established VC/PE firms, operating across multiple sectors with similar fund structures and LP base including government capital. Directly comparable to Partners Investment in strategy, geography, and target SME segment.

TypeDirect peer
Description

TS Investment is a Korean growth-stage investment firm operating PE and VC vehicles with comparable LP base including Korean financial institutions. Similar target SME segment and multi-sector strategy.

TypeDirect peer
Description

SKS PE is a Korean PE/VC firm operating multiple funds across growth-stage and buyout strategies, with comparable LP composition and a focus on Korean mid-market SMEs. Direct competitor for Korean growth equity mandates.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment136 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Partners Investment

Venture Capital and Private Equity Fund Managementpartnersi.co.kr

Partners Investment is a Seoul-based venture capital and private equity firm managing approximately 11,746억원 won (~$850M) across 21 funds, investing growth-stage capital into Korean SMEs across ICT, Bio & Healthcare, and Internet & Mobile sectors, with revenue from management fees and carried interest.

What Partners Investment does

Partners Investment Co., Ltd. (파트너스인베스트먼트) is a Seoul-based venture capital and private equity firm that traces its origins to 2000, when it was established as Partners Venture Capital. The firm rebranded to its current name in 2014 and completed a physical spin-off from Partners Holdings in 2019 to operate as an independent fund management platform. It manages 21 fund vehicles spanning venture, growth, secondary, M&A, co-investment, and global healthcare strategies, with total assets under management of approximately 11,746억원 won and roughly 7,150억원 won of cumulative capital deployed across a portfolio of 80+ companies as of March 2026.

The firm invests in Korean growth-stage SMEs across three core verticals: ICT (software, semiconductors, electronics, telecommunications), Bio & Healthcare (biotechnology, medical devices, healthcare services), and Internet & Mobile (digital media, fintech, gaming, e-learning). Recent 2026 deployments include co-investments in BOS Semiconductors (AI mobility accelerator chips, ~87 billion won Series A) and SOLIVIS (sulfide solid electrolytes for all-solid-state batteries, ~$13.7M Series C), signaling expansion into deep-tech hardware. Beyond capital, the firm provides hands-on stewardship including board representation, operational consulting in finance/sales/strategy, and periodic portfolio monitoring, governed by its adoption of the Korean Stewardship Code since October 2019.

Revenue is generated through management fees and carried interest on fund operations. The limited partner base is heavily institutional: government agencies (46%), financial institutions (32%), pensions and mutual aid associations (10%), and industrial/strategic companies (12%). Leadership is led by CEO Kim Jae-wan (former 12-year Samsung Venture Investment executive) with a senior team spanning biotech, semiconductors, mobility, and consulting backgrounds. The firm has received multiple "Best Fund" and industry awards from Korea Venture Investment, the Financial Services Commission, and Korea Growth Finance.

Partners Investment firmographics

Firmographics
Name
Partners Investment
Legal name
Partners Investment Co., Ltd. (파트너스인베스트먼트)
Website
https://partnersi.co.kr
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
Partners Investment is a Seoul-based venture capital and private equity firm managing approximately 11,746억원 won (~$850M) across 21 funds, investing growth-stage capital into Korean SMEs across ICT, Bio & Healthcare, and Internet & Mobile sectors, with revenue from management fees and carried interest.
Ownership category
akta.pro rank

Partners Investment industry classification

Industry
Product category
Venture Capital and Private Equity Fund Management
NAICS
All Other Financial Investment Activities (52399), Other Investment Pools and Funds (5259), Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282)
akta.pro primary industry
Multi-Sector / Generalist Growth Equity (FSANACAO)
akta.pro secondary industries
Technology & Software Growth Equity (FSANACAA), Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

  • Venture capital
  • Private equity funds
  • Growth-stage investment
  • Portfolio management
  • Stewardship services

Where Partners Investment is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Offices1 record

Markets served

Partners Investment business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Fund Management: Partners Investment generates revenue through managing multiple venture capital and private equity funds. The firm raises capital from LPs including government agencies (46%), financial institutions (32%), pensions (10%), and industrial companies (12%), and earns management fees and carried interest from fund operations and portfolio company exits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Partners Investment product offering

Product offering

Core offering

Partners Investment is a Seoul-based venture capital and private equity firm that manages 21 fund vehicles deploying growth capital into Korean SMEs. It raises capital from institutional limited partners and invests across the ICT, Bio & Healthcare, and Internet & Mobile sectors, while providing hands-on stewardship and value-creation support to portfolio companies through board participation, operational consulting, and strategic guidance.

Product overview

Partners Investment is a Korean venture capital and private equity firm that operates a diverse portfolio of investment funds targeting growth-stage SMEs. The firm manages multiple fund vehicles across different strategies including venture funds (Partners 2호 through 11호), secondary funds, growth support funds, M&A funds, healthcare-focused funds, and growth-together funds. Fund sizes range from 55억 원 to 2,400억 원 in committed capital. The firm focuses its investments on high-growth sectors including Software, Media/Entertainment, IT Services, Biotechnology, Medical Devices, Healthcare Services, Electronics/Semiconductors, Telecommunications, and Industrial/Energy. As a responsible partner to portfolio companies, Partners Investment provides stewardship services including financial management support, operational consulting, and strategic value enhancement. The firm has approximately 11,746억 원 in assets under management and 7,150억 원 in unrealized value as of March 2026.

Differentiator

Problem solved

Functional benefit

Products and services

  • Partners Venture Capital Fund Series (Partners 2nd through 11th Investment Partnerships) Sequential venture capital fund vehicles deploying growth capital into Korean SMEs across ICT, Bio & Healthcare, and Internet & Mobile sectors.
  • Partners M&A Investment Partnership M&A-focused private equity fund targeting buyout and consolidation opportunities in Korean SMEs.
  • Partners 7th Secondary Investment Partnership Secondary investment fund providing liquidity to investors in existing private equity and venture capital portfolios.
  • Partners Growth Support Investment Partnership (8th Fund) Growth capital fund providing expansion financing and operational support to high-growth Korean SMEs.
  • Partners Global Healthcare Fund Series (Funds 1, 3, and 4) Healthcare-focused private equity funds investing in biotechnology, medical devices, and healthcare services companies globally.
  • Investment Partnership Operation Service Core fund management service covering investment sourcing, due diligence, portfolio construction, and post-investment support across multiple sectors including Software, IT Services, Biotechnology, Medical Devices, Electronics, Semiconductors, Telecommunications, and Industrial/Energy.
  • Portfolio Company Stewardship Service Stewardship service for portfolio companies including periodic monitoring through ERP-based tracking, regular management consultations, board participation, voting rights exercise, and strategic value enhancement initiatives such as executive reinforcement and operational efficiency improvements.

Companies that use Partners Investment

Customer profile

Segments5 records

Ideal customer profiles2 records

Partners Investment technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Partners Investment partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Partners Investment competitors and assessment

Company assessment

Direct peers

  • Atinum Investment: Atinum is a major Korean VC/PE firm focused on growth-stage technology, biotech, and healthcare investments. It co-invested alongside Partners Investment in BOS Semiconductors' Series A, indicating directly overlapping deal pipelines in Korean deep-tech.
  • Premier Partners: Premier Partners is a Korean VC/PE firm with comparable growth-stage and sector-specialized focus, and is a previous employer of Partners Investment's Managing Director Sim Su-min. Operates similar fund vintages targeting Korean SMEs.
  • LB Investment: LB Investment is a leading Korean growth-stage VC/PE firm with strong ICT and biotech sector coverage and a comparable LP base anchored by Korean institutional capital. Directly competes for Korean SME growth deals.
  • Smilegate Investment: Smilegate Investment is a Korean VC/PE firm with strong deep-tech and gaming/internet focus. Co-invested with Partners Investment in BOS Semiconductors' Series A, indicating directly overlapping Korean deep-tech deal flow.
  • Mirae Asset Venture Investment: Mirae Asset Venture Investment is a top-tier Korean VC affiliate of Mirae Asset Group with multi-sector investment focus including ICT, biotech, and consumer. Directly comparable in fund scale, LP composition, and sector verticals.
  • Daesung Venture Capital: Daesung Venture Capital is a Korean VC firm with sector coverage overlapping Partners Investment's ICT and bio verticals. It is a previous employer of Partners Investment team member Kim Jun-soo.
  • Korea Investment Partners: Korea Investment Partners is one of Korea's largest and most established VC/PE firms, operating across multiple sectors with similar fund structures and LP base including government capital. Directly comparable to Partners Investment in strategy, geography, and target SME segment.
  • TS Investment: TS Investment is a Korean growth-stage investment firm operating PE and VC vehicles with comparable LP base including Korean financial institutions. Similar target SME segment and multi-sector strategy.
  • SKS PE: SKS PE is a Korean PE/VC firm operating multiple funds across growth-stage and buyout strategies, with comparable LP composition and a focus on Korean mid-market SMEs. Direct competitor for Korean growth equity mandates.

Broad incumbents

  • KB Investment: KB Investment is the venture/PE arm of KB Financial Group, one of Korea's largest financial conglomerates. Co-invested alongside Partners Investment in BOS Semiconductors. Larger and more diversified, but directly competes for top Korean growth deals with greater capital backing.

Market position

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Partners Investment social profiles

Digital presence

Partners Investment financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Partners Investment leadership team

Management profile

Number of profiles

Profiles5 records

Partners Investment funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Partners Investment M&A and investment

M&A and investment

M&A

Investments136 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Partners Investment

What does Partners Investment do?

Partners Investment is a Seoul-based venture capital and private equity firm that manages 21 fund vehicles deploying growth capital into Korean SMEs. It raises capital from institutional limited partners and invests across the ICT, Bio & Healthcare, and Internet & Mobile sectors, while providing hands-on stewardship and value-creation support to portfolio companies through board participation, operational consulting, and strategic guidance.

Is Partners Investment a public or private company?

Partners Investment is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Partners Investment founded?

Partners Investment was founded in 2000. It employs 11 to 50 people.

Where is Partners Investment based?

Partners Investment is headquartered in Seoul, South Korea, in the Asia region.

How does Partners Investment make money?

One revenue line is on record: fund Management.

Who are Partners Investment's main competitors?

Direct peers on record are Atinum Investment, Premier Partners, LB Investment, Smilegate Investment, Mirae Asset Venture Investment, Daesung Venture Capital, Korea Investment Partners, TS Investment and SKS PE. KB Investment is listed as a broad incumbent.

Does Partners Investment have an API?

No public API is recorded for Partners Investment.

What industry is Partners Investment in?

Partners Investment's product category is Venture Capital and Private Equity Fund Management. Its primary akta.pro industry code is FSANACAO, Multi-Sector / Generalist Growth Equity, with a secondary code of FSANACAA, Technology & Software Growth Equity. Its NAICS code is 52399 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Venture Capital Access OnlineXCENA Raises $135M Series B to Accelerate Deployment of Memory-Centric Computing SolutionsXCENA closed a $135 million Series B round co-led by Atinum and IMM, bringing total funding to $185 million at a $570 million valuation. The funds will scale customer deployments and advance its MX1 computational memory solution. The company is pursuing additional international fundraising.StartuptodaySenix secures 12.5 billion won in Series B funding... Global clinical and commercialization efforts intensify.Senix Biotech has secured 12.5 billion won in Series B funding from multiple investors including SBI Investment, Partners Investment, Ajou IB Investment, CKD Startup Investment, SL Investment, Intervalue Investment, and Scale Up Partners to advance its global clinical development and commercialization strategy. The company is developing CX213, the world's first cerium oxide-based nanozyme therapeutic agent targeting severe acute inflammatory diseases, which is poised to enter Phase 2 clinical trials in the United States. The funding will support establishing GMP manufacturing facilities while the company pursues licensing-out opportunities and strategic partnerships with global pharmaceutical companies.Einfomax'AI system semiconductor design' Boss Semiconductor raises 87 billion won in Series A fundingBoss Semiconductor, a Korean fabless AI semiconductor startup for mobility applications, has secured approximately 87 billion won in Series A funding from a consortium of investors including Atinum Investment, Partners Investment, Korea Development Bank, KB Investment, Smilegate Investment, and others. The company is developing AI semiconductor solutions including the high-performance mobility AI accelerator Eagle-N, scheduled for tape-out in the first half of this year, and recently won over 24 billion won in ASIC development projects from major Japanese automotive groups while conducting joint development with a European car manufacturer for Eagle-N. The investment will be used for Eagle-N mass production and establishing a global sales network targeting the growing EV and autonomous driving markets in China.SubstackAI Drug Discovery & Neurotech Lead Week's Deals | StartUp Health Insights: Week of Mar 18, 2025Insilico Medicine raised $110 million in funding led by Value Partners Group to support its generative AI-driven drug discovery efforts. The week's health innovation deals included significant capital raises for Arbor Biotechnologies ($73.9M), MicroTransponder ($65M), and Vori Health ($53M). These investments span various sectors including biotech, medical devices, and digital health platforms across multiple global regions.Business Wire BlogGordonMD Global Investments® LP (US) and Partners Investments Co., Inc. (South Korea) Announce Biopharmaceutical Investment CollaborationGordonMD Global Investments LP and Partners Investment Co., Ltd. have announced a joint investment collaboration to invest in biopharmaceutical companies across the US and South Korea. The partnership aims to leverage the combined expertise of both firms to support innovation and help South Korean biotech firms expand into the U.S. market.PlatumConstruction process automation solution company 'Spanner' raises 15 billion won in Series B round funding.Construction automation company Spanner secured 15 billion won in Series B funding led by Korea Investment Partners, with KB Investment and Partners Investment joining as new shareholders. The company reported that its revenue has already surpassed last year's total, driven largely by overseas sales including a recent $2 million contract in North America for solar pile construction automation solutions. Spanner plans to utilize the investment to expand its global footprint, targeting projects in Australia and Japan following recent activities in Vietnam.Yakup[Pharmaceutical News] Duesel Biotherapeutics successfully raises 9 billion won in investmentDucel Bio Therapeutics announced on the 29th that it successfully raised 9 billion won in Series B investment from Partners Investment, Korea Development Bank, and other financial institutions. The company plans to use these funds to enhance its 'en-aPLTTM' artificial platelet production platform and develop mass production technology for commercialization by 2026.PinpointnewsSurginex secures 8.5 billion won in Series B funding... accelerating technology advancement.Surgenex completed its Series B funding round, raising 8.5 billion won from investors including Kiwoom Investment and POSCO Technology Investment, bringing total accumulated investment to 12.5 billion won. The company plans to use the funds to establish mass production processes for its lipid nanoparticle technology and secure global licenses. This development supports Surgenex's strategy to expand partnerships in gene and cell therapy therapeutics.FinSMEsAdcentrx Extends Series A+ Financing to $51MAdcentrx Therapeutics extended its Series A+ financing round by $13 million, bringing the total raised to $51 million. The additional capital was provided by Quan Capital and Partners Investment to advance the company's proprietary ADC therapeutic pipeline in clinical trials.PedailyAdcentrx宣布A+轮融资增加至5100万美元Adcentrx Therapeutics announced the expansion of its Series A+ financing by an additional $13 million, bringing the total raised in this round to $51 million. The company secured new investors Quan Chuang Capital and Partners Investment to accelerate the clinical development of its ADC pipeline, specifically the lead candidate ADRX-0706. Guangyuan Capital served as the exclusive financial advisor for the transaction.